Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The Company’s segments include Scientific Equipment and Security Services. Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology Company that develops, manufactures, and sells magnetic resonance (MR) products for security, pharmaceutical, biotech, nutraceutical, chemical, food, materials, education, life science and medical applications. Security Services, focuses on providing security services, namely providing preventative and oncall maintenance services, as well as installation, of detection and analysis equipment. It offers commercial security equipment installation and maintenance services to a variety of customers in North America. It provides airport security equipment maintenance services in each province and territory of Canada.


TSXV:NSCI - Post by User

Comment by Oilytrader1on May 27, 2022 4:17pm
308 Views
Post# 34713342

RE:RE:160M CONTRACT

RE:RE:160M CONTRACTrunning a quick NPV on the contract with a 30% gross margin assumption, and 10% discount rate, i value the base case contract of $160MM @ $0.43 accretive to fair market value, and $0.62 accretive if they receive an extension for an additional 5 years, all discounted back to today. 

Assuming they hit their targets with base business, i would project end of year revenue @ $44MM, 2023 end of year @ $84MM, and 2024 $ 124MM.


With market cap at $101MM, or 1.2x  2023E revenue multiple. NSCI looks grossly undervalued. my 12month target is closer to  $3.00-$3.50 assuming 3x 2023E revenue. 

Thoughts?

Oily
<< Previous
Bullboard Posts
Next >>